WNK2 and Langerhans cell histiocytosis: Langerhans cell histiocytosis (LCH) is a disease originating from abnormal proliferation of CD1a+/CD207+ myeloid dendritic cells and characterized by activation of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathway [1, 2].